These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 27354484)

  • 1. Quality of Life in Patients With Advanced Cancer: Differential Association With Performance Status and Systemic Inflammatory Response.
    Laird BJ; Fallon M; Hjermstad MJ; Tuck S; Kaasa S; Klepstad P; McMillan DC
    J Clin Oncol; 2016 Aug; 34(23):2769-75. PubMed ID: 27354484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "How Long Have I Got?"-A Prospective Cohort Study Comparing Validated Prognostic Factors for Use in Patients with Advanced Cancer.
    Simmons C; McMillan DC; Tuck S; Graham C; McKeown A; Bennett M; O'Neill C; Wilcock A; Usborne C; Fearon KC; Fallon M; Laird BJ;
    Oncologist; 2019 Sep; 24(9):e960-e967. PubMed ID: 30975922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) - Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS).
    Roncolato FT; Berton-Rigaud D; O'Connell R; Lanceley A; Sehouli J; Buizen L; Okamoto A; Aotani E; Lorusso D; Donnellan P; Oza A; Avall-Lundqvist E; Berek J; Hilpert F; Ledermann JA; Kaminsky MC; Stockler MR; King MT; Friedlander M
    Gynecol Oncol; 2018 Jan; 148(1):36-41. PubMed ID: 29107348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of quality of life in patients with incurable cancer.
    Daly LE; Dolan RD; Power DG; Ní Bhuachalla É; Sim W; Cushen SJ; Fallon M; Simmons C; McMillan DC; Laird BJ; Ryan AM
    Cancer; 2020 Jun; 126(12):2872-2882. PubMed ID: 32267548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An exploratory study examining the relationship between performance status and systemic inflammation frameworks and cytokine profiles in patients with advanced cancer.
    Dolan RD; Laird BJA; Klepstad P; Kaasa S; Horgan PG; Paulsen Ø; McMillan DC
    Medicine (Baltimore); 2019 Sep; 98(37):e17019. PubMed ID: 31517821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in patients with advanced cancer: a comparison of clinicopathological factors and the development of an inflammation-based prognostic system.
    Laird BJ; Kaasa S; McMillan DC; Fallon MT; Hjermstad MJ; Fayers P; Klepstad P
    Clin Cancer Res; 2013 Oct; 19(19):5456-64. PubMed ID: 23938289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatigue in Patients With Advanced Terminal Cancer Correlates With Inflammation, Poor Quality of Life and Sleep, and Anxiety/Depression.
    Rodrigues AR; Trufelli DC; Fonseca F; de Paula LC; Giglio AD
    Am J Hosp Palliat Care; 2016 Dec; 33(10):942-947. PubMed ID: 26324072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression-A Major Contributor to Poor Quality of Life in Patients With Advanced Cancer.
    Grotmol KS; Lie HC; Hjermstad MJ; Aass N; Currow D; Kaasa S; Moum TÅ; Pigni A; Loge JH;
    J Pain Symptom Manage; 2017 Dec; 54(6):889-897. PubMed ID: 28803091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the prognostic value of MUST, ECOG-PS, mGPS and CT derived body composition analysis in patients with advanced lung cancer.
    Abbass T; Dolan RD; MacLeod N; Horgan PG; Laird BJ; McMillan DC
    Clin Nutr ESPEN; 2020 Dec; 40():349-356. PubMed ID: 33183562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study.
    Proctor MJ; Talwar D; Balmar SM; O'Reilly DS; Foulis AK; Horgan PG; Morrison DS; McMillan DC
    Br J Cancer; 2010 Sep; 103(6):870-6. PubMed ID: 20717110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of the pretreatment glasgow prognostic score in patients with advanced inoperable non-small cell lung cancer.
    Leung EY; Scott HR; McMillan DC
    J Thorac Oncol; 2012 Apr; 7(4):655-62. PubMed ID: 22425914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between pro-inflammatory cytokines and pain, appetite and fatigue in patients with advanced cancer.
    Paulsen Ø; Laird B; Aass N; Lea T; Fayers P; Kaasa S; Klepstad P
    PLoS One; 2017; 12(5):e0177620. PubMed ID: 28542626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of nutrition parameters including bioelectrical impedance and systemic inflammatory response with quality of life and prognosis in patients with advanced non-small-cell lung cancer: a prospective study.
    Sánchez-Lara K; Turcott JG; Juárez E; Guevara P; Núñez-Valencia C; Oñate-Ocaña LF; Flores D; Arrieta O
    Nutr Cancer; 2012; 64(4):526-34. PubMed ID: 22489794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation and Performance Status: The Cornerstones of Prognosis in Advanced Cancer.
    Rocha BMM; Dolan RD; Paiva CE; McGovern J; Paiva BSR; Preto DD; McMillan DC; Maia YCP; Laird BJ
    J Pain Symptom Manage; 2023 Apr; 65(4):348-357. PubMed ID: 36493981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival.
    Quinten C; Maringwa J; Gotay CC; Martinelli F; Coens C; Reeve BB; Flechtner H; Greimel E; King M; Osoba D; Cleeland C; Ringash J; Schmucker-Von Koch J; Taphoorn MJ; Weis J; Bottomley A
    J Natl Cancer Inst; 2011 Dec; 103(24):1851-8. PubMed ID: 22157640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between global and specific components of quality of life, assessed with the EORTC QLQ-C30 in a sample of 2019 cancer patients.
    Hinz A; Mehnert A; Dégi C; Reissmann DR; Schotte D; Schulte T
    Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 26568527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the prognostic value of ECOG-PS, mGPS and BMI/WL: Implications for a clinically important framework in the assessment and treatment of advanced cancer.
    Dolan RD; Daly L; Sim WMJ; Fallon M; Ryan A; McMillan DC; Laird BJ
    Clin Nutr; 2020 Sep; 39(9):2889-2895. PubMed ID: 31926762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between the insulin-like growth factor-1 axis, weight loss, an inflammation-based score and survival in patients with inoperable non-small cell lung cancer.
    Meek CL; Wallace AM; Forrest LM; McMillan DC
    Clin Nutr; 2010 Apr; 29(2):206-9. PubMed ID: 19748165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of overall quality of life in preterminal cancer patients.
    Beijer S; Kempen GI; Pijls-Johannesma MC; de Graeff A; Dagnelie PC
    Int J Cancer; 2008 Jul; 123(1):232-5. PubMed ID: 18412247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.